Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.
Angus HodderAvijeet Kumar MishraAmir EnshaeiSusan BairdIsmail ElbeshlawiDenise BonneyKatherine CleshamMichelle CumminsAditi VediBrenda GibsonLindsay GeorgeDanielle InghamGalina JigoulinaDonna LancasterKatherine LindsayMajid MadniAndrea MaloneBethany MitchellJohn P MoppettJayashree MotwaniAnthony V MoormanKatharine PatrickLamia SamrinSanjay TewariIndu ThakurDavid O'ConnorSujith SamarasingheAjay VoraPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Blina is safe and effective in first-line treatment of chemotherapy-intolerant CYP with ALL.